Osaka: Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immune Globulin Infusion 10% (Human ... at level comparable to treatment with ...

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (fSCIG) Approved in Japan for Agammaglobulinemia ...

X-linked agammaglobulinemia (XLA) is an immune disorder that causes extremely ... a healthcare professional will administer immunoglobulin via an intravenous drip (through a vein) or subcutaneous ...

has shown a remarkable improvement following treatment with intravenous immunoglobulin (IVIG) therapy. After experiencing progressive tightness in his back and legs, the patient found it ...

A New York judge ruled that former President Donald Trump cannot claim presidential immunity to overturn his felony conviction. The decision from Judge Juan Merchan marks a temporary setback for ...

Children with newly diagnosed immune thrombocytopenia (ITP) treated with eltrombopag ... include corticosteroids, intravenous immunoglobulin (IVIg), and anti-D globulin; however, side effects ...

Corticosteroids, intravenous immunoglobulin (IVIg), and anti-D globulin are commonly used as first-line treatments for newly diagnosed immune thrombocytopenia (ITP). Eltrombopag (epag), a ...

His work is focused on cytokine regulation and the clinical uses of intravenous gamma globulin and other immunosuppressive agents. Ashley Vo, PhD, is Director of Transplant Immunotherapy at Cedars ...

Antiphospholipid antibodies can arise transiently during viral infections, and treatment with corticosteroids and intravenous immunoglobulin (IVIG) masked the condition ... with plasma exchange or ...